Drug Trial Radar · NCT01720667
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Last checked: Nov 19, 2026Latest source record: Aug 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Mar 2013
Primary completion
Oct 31, 2017
Study completion Jul 31, 2019
Sponsor
- Lead sponsor
- Richard H. HaasAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of California, San Diego; Rady Children's Hospital, San Diego; Auckland City Hospital; Sharp Mary Birch Hospital for Women & Newborns; UCSF Benioff Children's Hospital Oakland; Food and Drug Administration (FDA)
- First posted
- Nov 2, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 minutes, up to 14 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A new anticonvulsant, levetiracetam will be studied to treat seizures in newborn infants. Current treatments for the brain damaging complication of neonatal seizures are unsatisfactory. Monitoring for seizure detection will be tested at five (5) US sites and one (1) international site using the internet.
Conditions
- Neonatal Seizures
Interventions
Intravenous levetiracetamDrug
Intravenous load of levetiracetam (40 to 60 mg/kg) following identification of EEG confirmed neonatal seizure.
Intravenous phenobarbitalDrug
Intravenous load of phenobarbital (20 to 40 mg/kg) following EEG confirmation of seizure activity load.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Neonates With Seizure Cessation When Given Levetiracetam (40-60 mg/kg) as First Line Therapy Compared to Phenobarbital (20-40mg/kg)Time frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, San Diego Medical Center / Neonatal Intensive Care Unit (NICU)
San Diego, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.